3
Announcements
Trials
Browse
Landscape
Status
Completed
3
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other
1
Conditions
Breast Neoplasms
26
Neoplasms
18
Prostatic Neoplasms
11
Lung Neoplasms
7
Sarcoma
6
Pancreatic Neoplasms
5
Ovarian Neoplasms
5
Colorectal Neoplasms
5
Uterine Cervical Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Hematologic Neoplasms
4
Head and Neck Neoplasms
4
Oropharyngeal Neoplasms
3
Lymphoma
3
Esophageal Neoplasms
3
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Signs and Symptoms
2
Papillomavirus Infections
2
Pain
2
Multiple Myeloma
2
Melanoma
2
Gastrointestinal Neoplasms
2
Financial Stress
2
Endometrial Neoplasms
2
Depression
2
Coitus
2
Chronic Pain
2
Central Nervous System Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Interventions
trametinib
1
sotorasib
1
selpercatinib
1
pembrolizumab
1
osimertinib
1
lorlatinib
1
dabrafenib
1
cemiplimab
1
brigatinib
1
alectinib
1
Surveys and Questionnaires
1
Pemetrexed
1
Paclitaxel
1
Nivolumab
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Sexual Dysfunction, Physiological
×
Surveys and Questionnaires
×
Clear all
NCT06458764
2025-06-24
SEXCHECK
Candiolo Cancer Institute - IRCCS
Recruiting
150 enrolled